1. Home
  2. Stock quotes
  3. Supernus Pharmaceuticals
  4. Financial Statements
  5. Balance Sheet
  6. Cash and Cash Equivalents
Supernus Pharmaceuticals logo
Supernus Pharmaceuticals SUPN
$ 35.71 -1.14%
mail-toReport an Error

Quarterly report 2024-Q3
added 11-04-2024

report update icon

Supernus Pharmaceuticals Cash and Cash Equivalents 2011-2024 | SUPN

Annual Cash and Cash Equivalents Supernus Pharmaceuticals

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
93.1 M 203 M 289 M 181 M 192 M 100 M 66.4 M 33.5 M 36.4 M 33 M 40.3 M 48.5 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
289 M 33 M 110 M

Quarterly Cash and Cash Equivalents Supernus Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
31.7 M 52.1 M 63.4 M 75.1 M 95 M 24.7 M 58.4 M 93.1 M 111 M 173 M 116 M 203 M 215 M 224 M 256 M 289 M 289 M 289 M 289 M 181 M 181 M 181 M 181 M 192 M 192 M 192 M 192 M 100 M 100 M 100 M 100 M 66.4 M 66.4 M 66.4 M 66.4 M 33.5 M 33.5 M 33.5 M 33.5 M 36.4 M 36.4 M 36.4 M 36.4 M 33 M 33 M 33 M 33 M 40.3 M 40.3 M 40.3 M 40.3 M 48.5 M 48.5 M 48.5 M 48.5 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
289 M 24.7 M 107 M